Nymox Pharmaceutical {NASDAQ: NYMX} corporate risk has been rated as “extremely high” by Capital Market Laboratories.
The data is drawn from many ppints within the option market.
The full article can be read here:
Read the full article HERE
Nymox Pharmaceutical {NASDAQ: NYMX} corporate risk has been rated as “extremely high” by Capital Market Laboratories.
The data is drawn from many ppints within the option market.
The full article can be read here:
Read the full article HERE